-
ARWR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Arrowhead Pharmaceuticals (ARWR)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Sep 24 | Sep 23 | Sep 22 | Sep 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 102.69 mm | 102.69 mm | 102.69 mm | 102.69 mm | 102.69 mm | 102.69 mm |
Cash burn (monthly) | (no burn) | 683.83 k | 57.60 mm | 51.22 mm | 45.74 mm | 38.57 mm |
Cash used (since last report) | n/a | 2.75 mm | 231.66 mm | 206.00 mm | 183.96 mm | 155.13 mm |
Cash remaining | n/a | 99.93 mm | -128.97 mm | -103.31 mm | -81.27 mm | -52.44 mm |
Runway (months of cash) | n/a | 146.1 | -2.2 | -2.0 | -1.8 | -1.4 |
13F holders | Current |
---|---|
Total holders | 270 |
Opened positions | 36 |
Closed positions | 37 |
Increased positions | 89 |
Reduced positions | 88 |
13F shares | Current |
---|---|
Total value | 1.76 tn |
Total shares | 95.76 mm |
Total puts | 423.10 k |
Total calls | 152.00 k |
Total put/call ratio | 2.8 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 15.84 mm | $306.74 bn |
Vanguard | 12.23 mm | $236.88 bn |
Avoro Capital Advisors | 8.89 mm | $172.18 bn |
STT State Street | 6.35 mm | $123.08 bn |
FMR | 6.07 mm | $117.53 bn |
Slate Path Capital | 4.89 mm | $94.62 bn |
T. Rowe Price Investment Management | 3.57 mm | $69.24 mm |
Geode Capital Management | 2.96 mm | $57.43 bn |
Siren, L.L.C. | 2.46 mm | $47.63 bn |
Ubs Global Asset Management Americas | 2.15 mm | $41.73 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
23 Jan 25 | Olukotun Adeoye Y | Common Stock | Sell | Dispose S | No | Yes | 21 | 959 | 20.14 k | 35,781 |
7 Jan 25 | Patrick O'Brien | Common Stock | Sell | Dispose S | No | Yes | 19.69 | 8,000 | 157.52 k | 527,201 |
7 Jan 25 | Kenneth Allen Myszkowski | Common Stock | Sell | Dispose S | No | No | 19.69 | 10,000 | 196.90 k | 455,433 |
7 Jan 25 | Kenneth Allen Myszkowski | Common Stock | Sell | Dispose S | No | Yes | 19.7 | 8,000 | 157.60 k | 465,433 |
6 Jan 25 | Patrick O'Brien | Common Stock | Sell | Dispose S | No | Yes | 20.1 | 9,526 | 191.47 k | 535,201 |
6 Jan 25 | Patrick O'Brien | Common Stock | Sell | Dispose S | No | Yes | 19.69 | 19,658 | 387.07 k | 544,727 |
6 Jan 25 | James C Hamilton | Common Stock | Sell | Dispose S | No | Yes | 20.11 | 10,971 | 220.63 k | 272,122 |
6 Jan 25 | James C Hamilton | Common Stock | Sell | Dispose S | No | Yes | 19.68 | 21,758 | 428.20 k | 283,093 |
6 Jan 25 | Kenneth Allen Myszkowski | Common Stock | Sell | Dispose S | No | Yes | 20.1 | 9,402 | 188.98 k | 473,433 |
6 Jan 25 | Kenneth Allen Myszkowski | Common Stock | Sell | Dispose S | No | Yes | 19.68 | 17,765 | 349.62 k | 482,835 |